loading page

Viral wheezing in early childhood as a risk factor for asthma in young adulthood
  • +1
  • Paula Heikkilä,
  • Matti Korppi,
  • Marja Ruotsalainen,
  • Katri Backman
Paula Heikkilä
Tampere University Hospitak
Author Profile
Matti Korppi
Tampere University and University Hospital, Tampere, Finland
Author Profile
Marja Ruotsalainen
Kuopio University Hospital
Author Profile
Katri Backman
Kuopio University Hospital
Author Profile

Abstract

Background: There is an increased risk of asthma after viral wheezing episodes in early childhood, but unfortunately, prospective longitudinal data are lacking. The aim of this cohort study was to evaluate the risk of asthma in young adulthood after hospitalization for viral wheezing episodes in early childhood. Methods: The original cohort comprised 100 individuals aged <24 months who were hospitalized for viral wheezing episodes in 1992–1993. After the index episode, data on a diagnosis of asthma 1 year later and at median ages of 4.0, 7.2 and 12.3 years were recorded in follow-up visits. Forty-nine individuals attended the latest follow-up visit at the age of 17-20 years. Current asthma was diagnosed based on symptoms at the time of the last follow-up, use of inhaled corticosteroids and peak expiratory flow (PEF) monitoring. Results: Twenty-six (53%) of the 49 cohort individuals had asthma at a mean age of 18.8 years. In multivariate analyses, a diagnosis of asthma 1 year after index hospitalization and at ages 4.0, 7.2 and 12.3 years were significant risk factors for current asthma (adjusted odds ratios [aORs] of 7.13, 8.86, 8.05 and 21.16, respectively). Atopic dermatitis in infancy (aOR: 4.20) and eosinophilia on admission (5.18) were also significant predictive factors for asthma. Conclusion: Over half (26/49) of the participants who had been hospitalized for viral wheezing episodes in early childhood had asthma in young adulthood. An asthma diagnosis at any age during childhood, as well as eosinophilia in early childhood, were independent significant predictive factors for asthma.

Peer review status:UNDER REVIEW

20 Apr 2021Submitted to Pediatric Pulmonology
21 Apr 2021Assigned to Editor
21 Apr 2021Submission Checks Completed
29 Apr 2021Reviewer(s) Assigned
04 Jun 2021Review(s) Completed, Editorial Evaluation Pending